110 related articles for article (PubMed ID: 23395573)
1. Mechanism of action of salinomycin on growth and migration in pancreatic cancer cell lines.
He L; Wang F; Dai WQ; Wu D; Lin CL; Wu SM; Cheng P; Zhang Y; Shen M; Wang CF; Lu J; Zhou YQ; Xu XF; Xu L; Guo CY
Pancreatology; 2013; 13(1):72-8. PubMed ID: 23395573
[TBL] [Abstract][Full Text] [Related]
2. Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133
Klose J; Eissele J; Volz C; Schmitt S; Ritter A; Ying S; Schmidt T; Heger U; Schneider M; Ulrich A
BMC Cancer; 2016 Nov; 16(1):896. PubMed ID: 27855654
[TBL] [Abstract][Full Text] [Related]
3. Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.
Wang F; He L; Dai WQ; Xu YP; Wu D; Lin CL; Wu SM; Cheng P; Zhang Y; Shen M; Wang CF; Lu J; Zhou YQ; Xu XF; Xu L; Guo CY
PLoS One; 2012; 7(12):e50638. PubMed ID: 23284640
[TBL] [Abstract][Full Text] [Related]
4. Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines.
Dong TT; Zhou HM; Wang LL; Feng B; Lv B; Zheng MH
Ann Surg Oncol; 2011 Jun; 18(6):1797-804. PubMed ID: 21267784
[TBL] [Abstract][Full Text] [Related]
5. Salinomycin nanoparticles interfere with tumor cell growth and the tumor microenvironment in an orthotopic model of pancreatic cancer.
Daman Z; Faghihi H; Montazeri H
Drug Dev Ind Pharm; 2018 Sep; 44(9):1434-1442. PubMed ID: 29619850
[TBL] [Abstract][Full Text] [Related]
6. Enhanced cell migration and invasion of CD133+ pancreatic cancer cells cocultured with pancreatic stromal cells.
Moriyama T; Ohuchida K; Mizumoto K; Cui L; Ikenaga N; Sato N; Tanaka M
Cancer; 2010 Jul; 116(14):3357-68. PubMed ID: 20564084
[TBL] [Abstract][Full Text] [Related]
7. Salinomycin inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cell in vitro and suppresses tumor growth in vivo.
Wu D; Zhang Y; Huang J; Fan Z; Shi F; Wang S
Biochem Biophys Res Commun; 2014 Jan; 443(2):712-7. PubMed ID: 24333874
[TBL] [Abstract][Full Text] [Related]
8. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.
Song KS; Jing K; Kim JS; Yun EJ; Shin S; Seo KS; Park JH; Heo JY; Kang JX; Suh KS; Wu T; Park JI; Kweon GR; Yoon WH; Hwang BD; Lim K
Pancreatology; 2011; 11(6):574-84. PubMed ID: 22213040
[TBL] [Abstract][Full Text] [Related]
9. Salinomycin inhibits growth of pancreatic cancer and cancer cell migration by disruption of actin stress fiber integrity.
Schenk M; Aykut B; Teske C; Giese NA; Weitz J; Welsch T
Cancer Lett; 2015 Mar; 358(2):161-169. PubMed ID: 25529011
[TBL] [Abstract][Full Text] [Related]
10. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
11. Salinomycin enhances radiotherapy sensitivity and reduces expressions of BIRC5 and NEIL2 in nasopharyngeal carcinoma.
Chang Y; Geng Q; Bao Q; Hu P
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6409-6416. PubMed ID: 32572938
[TBL] [Abstract][Full Text] [Related]
12. Reversion of trichostatin A resistance via inhibition of the Wnt signaling pathway in human pancreatic cancer cells.
Wang B; Zou Q; Sun M; Chen J; Wang T; Bai Y; Chen Z; Chen B; Zhou M
Oncol Rep; 2014 Nov; 32(5):2015-22. PubMed ID: 25224651
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of growth inhibitory response of Resveratrol and Salinomycin combinations against triple negative breast cancer cells.
Rai G; Suman S; Mishra S; Shukla Y
Biomed Pharmacother; 2017 May; 89():1142-1151. PubMed ID: 28298074
[TBL] [Abstract][Full Text] [Related]
14. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
15. Autophagy inhibition enhances antiproliferative effect of salinomycin in pancreatic cancer cells.
Endo S; Nakata K; Sagara A; Koikawa K; Ando Y; Kibe S; Takesue S; Nakayama H; Abe T; Okumura T; Moriyama T; Miyasaka Y; Ohuchida K; Ohtsuka T; Mizumoto K; Nakamura M
Pancreatology; 2017; 17(6):990-996. PubMed ID: 28927939
[TBL] [Abstract][Full Text] [Related]
16. Salinomycin inhibits Akt/NF-κB and induces apoptosis in cisplatin resistant ovarian cancer cells.
Parajuli B; Lee HG; Kwon SH; Cha SD; Shin SJ; Lee GH; Bae I; Cho CH
Cancer Epidemiol; 2013 Aug; 37(4):512-7. PubMed ID: 23545383
[TBL] [Abstract][Full Text] [Related]
17. The NK1 receptor antagonist NKP608 inhibits proliferation of human colorectal cancer cells via Wnt signaling pathway.
Niu XL; Hou JF; Li JX
Biol Res; 2018 May; 51(1):14. PubMed ID: 29843798
[TBL] [Abstract][Full Text] [Related]
18. The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells.
Yao HJ; Zhang YG; Sun L; Liu Y
Biomaterials; 2014 Nov; 35(33):9208-23. PubMed ID: 25115788
[TBL] [Abstract][Full Text] [Related]
19. Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment.
Kim YJ; Liu Y; Li S; Rohrs J; Zhang R; Zhang X; Wang P
Mol Pharm; 2015 Aug; 12(8):2811-22. PubMed ID: 26098197
[TBL] [Abstract][Full Text] [Related]
20. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
Sun XD; Liu XE; Huang DS
Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
